News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Week In Review: Luye Pharma Group Ltd. To Raise $750 Million In Hong Kong IPO


2/17/2014 9:02:45 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

February 15, 2014 -- Luye Pharma will stage a $750 million IPO in Hong Kong after having delisted from the Singapore exchange two years ago; CR Double-Crane will distribute a Sagent Pharma orphan drug in China; the CFDA established a priority review process for innovative medical devices that renders a decision within either 60 or 40 working days; pharmaceutical foreign trade for China – in-bound and out-bound – rose 10% to $89.7 billion in 2013 with imports rising faster than exports; China researchers have created gold nanoshells that are designed to improve delivery of chemotherapies to tumors. More details….

Stock Symbols: (SHA: 600062) (NSDQ: SGNT)

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES